Weight loss has taken on a new shape in recent years, largely because of GLP-1 medications that have changed how people think about shedding pounds and the metabolic health gains that may come with it, beyond the numbers on the scale.
Even as these drugs have helped many people, they have also raised a range of concerns and practical challenges.
As part of a wider look at metabolic health, Everyday Health surveyed 858 U.S. adults who had been diagnosed with obesity or were using a GLP-1 drug for weight loss. The results highlighted these realities and how they vary depending on factors such as diagnosis status and age.
Continue reading for the survey’s main findings.
More from Digilifetrends
Once-weekly IcoSema lowers weight and systolic blood pressure in type 2 diabetes
A once-weekly injection that combines a long-acting basal insulin with semaglutide was linked to meaningful reductions in body weight, lower systolic blood pressure and better…
7 min read · Updated 2026-10-28Lilly’s experimental weight-loss drug outperforms Ozempic in study
(TNND) — Eli Lilly says a late-stage study indicates its experimental once-weekly injection retatrutide may help adults with Type 2 diabetes shed more weight than Ozempic, while…
3 min read · Updated 2026-10-28Lilly’s Experimental Drug Outperforms Ozempic in Weight-Loss Trial
A late-stage study indicates that Eli Lilly’s experimental weekly injection retatrutide may lead to greater weight loss than Ozempic in adults with Type 2 diabetes, while also…
3 min read · Updated 2026-10-28